Aytu Biopharma (AYTU) Non-Current Deffered Revenue (2015 - 2017)
Aytu Biopharma (AYTU) posted quarterly Non-Current Deffered Revenue of $1451.0 for Q2 2017, down 82.34% year-over-year from $8215.0 in Q2 2016, and down 53.48% quarter-over-quarter from $3119.0 in Q1 2017.
Aytu Biopharma (AYTU) Non-Current Deffered Revenue (2015 - 2017) Analysis & Trends
Aytu Biopharma (AYTU) has reported Non-Current Deffered Revenue for 3 consecutive years, with $1451.0 the latest figure, recorded in Q2 2017.
- In Q2 2017, Non-Current Deffered Revenue fell 82.34% year-over-year to $1451.0; the TTM figure through Jun 2017 stood at $1451.0 (down 82.34% YoY), while the FY2017 annual figure was $1451.0, down 82.34% from the prior year.
- Non-Current Deffered Revenue retreated to $1451.0 in Q2 2017 per AYTU's latest filing, from $3119.0 in the prior quarter.
- Across five years, Non-Current Deffered Revenue topped out at $383036.0 in Q4 2015 and bottomed at $1449.0 in Q2 2015.
- Historically, Non-Current Deffered Revenue has averaged $86833.1 across 3 years, with a median of $6455.0 in 2016.
- Annual changes were most pronounced in 2016 — Non-Current Deffered Revenue soared 466.94% — and 2017, when it plunged 99.14%.
- Aytu Biopharma's Non-Current Deffered Revenue stood at $383036.0 in 2015, then tumbled by 98.75% to $4787.0 in 2016, then sank by 69.69% to $1451.0 in 2017.
- Business Quant data shows AYTU's Non-Current Deffered Revenue at $1451.0 in Q2 2017, $3119.0 in Q1 2017, and $4787.0 in Q4 2016.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.78 Bn | 30.11 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.71 Bn | 22.91 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 22.25 Bn | 19.59 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.72 Bn | 17.83 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.57 Bn | 15.18 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.97 Bn | - | - |
| 10 | Aytu Biopharma | 24.70 Mn | -2.01 Mn | 7.60 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2017 | 1,451.00 |
| Mar 31, 2017 | 3,119.00 |
| Dec 31, 2016 | 4,787.00 |
| Sep 30, 2016 | 6,455.00 |
| Jun 30, 2016 | 8,215.00 |
| Mar 31, 2016 | 361,607.00 |
| Dec 31, 2015 | 383,036.00 |
| Sep 30, 2015 | 11,379.00 |
| Jun 30, 2015 | 1,449.00 |